Unicycive Therapeutics News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

11.11.24	Unicycive Says FDA Accepts NDA For Oxylanthanum Carbonate To Treat Patients With CKD On Dialysis (RTTNews)
04.03.24	Unicycive Therapeutics: FDA Grants Orphan Drug Designation To UNI-494 (RTTNews)
23.10.23	FDA, Unicycive Agree On Path To File NDA For Oxylanthanum Carbonate (RTTNews)
08.11.22	EQS-News: Unicycives Doug Jermasek, EVP-Corporate Development Discusses the Importance of Medication Compliance and the Issues with Pill Burden (EQS Group)
12.10.22	EQS-News: Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells (EQS Group)
23.09.22	EQS-News: How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication (EQS Group)
03.03.22	Unicycive to Present at Upcoming March Investor Conferences (PR Newswire)
02.02.22	Unicycive Announces Renazorb Pre-clinical and Clinical Data Selected for Presentation at National Kidney Foundation Spring Clinical Meeting (PR Newswire)
10.01.22	Unicycive Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference (PR Newswire)
29.11.21	Unicycive Therapeutics Receives Confirmatory Guidance on Renazorb Regulatory Pathway (PR Newswire)
11.11.21	Unicycive Therapeutics Announces Third Quarter 2021 Financial Results (PR Newswire)
26.10.21	Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate Strategy (PR Newswire)
15.09.21	Unicycive Therapeutics to be Added to Russell Microcap® Index (PR Newswire)
07.09.21	Unicycive Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference (PR Newswire)
16.08.21	Unicycive Therapeutics Announces Second Quarter 2021 Financial Results (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	302.80	1.30 %	K V
Alcon	76.88	0.65 %	K V
Sika	218.00	0.37 %	K V
Kuehne+Nagel Int	202.60	-0.20 %	K V
Logitech Intl	78.28	-0.33 %	K V
ABB	49.25	-1.44 %	K V
Holcim	87.68	-1.55 %	K V
Zurich Insur Gr	531.20	-1.63 %	K V
Roche Hldg G	267.20	-1.69 %	K V
UBS Group	29.78	-1.94 %	K V